Pfizer Inc (LTS:0Q1N)
$ 25.44 +0.49 (+1.97%) Market Cap: 144.83 Bil Enterprise Value: 196.63 Bil PE Ratio: 19.11 PB Ratio: 1.58 GF Score: 70/100

Q2 2026 Pfizer Inc Earnings Call Transcript

Aug 04, 2026 / 02:00PM GMT
Release Date Price: $25.44 (+1.97%)
Operator

Good day, everyone, and welcome to Pfizer's second quarter 2026 earnings conference call. Today's call is being recorded.

At this time, I would like to turn the call over to Francesca DiMartino, Chief Investor Relations Officer and Senior Vice President. Please go ahead, ma'am.

Francesca DeMartino
Pfizer Inc - Chief Investor Relations Officer and Senior Vice President

Good morning, and welcome to Pfizer's earnings call. I'm Francesca DiMartino, Chief Investor Relations Officer. On behalf of the Pfizer team, thank you for joining us.

This call is being made available via audio webcast at pfizer.com.

Earlier this morning, we released our results for the second quarter of 2026 via a press release that is available on our website at pfizer.com.

I'm joined today by Dr. Albert Bourla, our Chairman and CEO Dave Denton, our CFO Cecile Gagant, our incoming interim CFO and Chris Boschoff, our Chief Scientific Officer. After their prepared remarks, we will open the call for questions.

Members of our leadership team will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot